TABLE 2.
Treatments and outcome in stages II and III with curative surgery.
| Stages II (n = 165) and III (n = 115) | n = 280 |
|---|---|
| Adjuvant chemotherapy (n, %) | |
| Stage II (n = 163) | 26 (16.0%) |
| Stage III (n = 115) | 77 (67.0%) |
| Missing values | 2 |
| Recurrence (n, %) | |
| Stage II (n = 159) | 21 (13.2%) |
| Stage III (n = 114) | 27 (23.7%) |
| Missing values | 7 |
| 3-year time to recurrence (%) | |
| Stage II | 88.8% |
| Stage III | 76.2% |
| Median disease-free survival (months) | |
| Stage II | 87.1 ± 10.5 |
| Stage III | 76.7 ± 26.4 |
| Median overall survival (months) | |
| Stage II | 91.9 ± 8.2 |
| Stage III | 91.5 ± 8.6 |
| 5-year cancer-specific survival (%) | |
| Stage II | 88.8% |
| Stage III | 75.0% |